廣告
香港股市 已收市
  • 恒指

    16,541.42
    +148.58 (+0.91%)
     
  • 國指

    5,810.79
    +82.66 (+1.44%)
     
  • 上證綜指

    3,010.66
    +17.52 (+0.59%)
     
  • 滬深300

    3,520.96
    +18.18 (+0.52%)
     
  • 美元

    7.8261
    +0.0005 (+0.01%)
     
  • 人民幣

    0.9228
    0.0000 (0.00%)
     
  • 道指

    39,807.37
    +47.29 (+0.12%)
     
  • 標普 500

    5,254.35
    +5.86 (+0.11%)
     
  • 納指

    16,379.46
    -20.06 (-0.12%)
     
  • 日圓

    0.0515
    +0.0000 (+0.02%)
     
  • 歐元

    8.4385
    -0.0020 (-0.02%)
     
  • 英鎊

    9.8810
    +0.0050 (+0.05%)
     
  • 紐約期油

    83.11
    -0.06 (-0.07%)
     
  • 金價

    2,254.80
    +16.40 (+0.73%)
     
  • Bitcoin

    70,714.30
    +1,149.52 (+1.65%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     

Insulet Shares Jump After Q3 Earnings Surpass Expectations, Improved Annual Guidance

  • Insulet Corp (NASDAQ: PODD) posted an adjusted EPS of $0.45 in Q3, surpassing the consensus of $0.15.

  • Insulet recorded a bottom-line dip into the red of $(5.2) million from profits of $12.6 million a year ago. However, the company registered sales growth of 23.7% Y/Y to $340.8 million, beating the consensus of $312.52 million.

  • The company reported total Omnipod automated insulin delivery system revenue of $326.1 million. Insulet initiated the full market launch of the latest-generation Omnipod 5 device in U.S. pharmacies earlier this year.

  • Related: FDA Approves Insulet's Omnipod Automated Insulin System For Patients Two Years & Above.

  • Additionally, Insulet recently developed a basal-only pod for individuals with type 2 diabetes. According to a news release, it plans to submit to the FDA for 510(k) clearance soon.

  • Insulet expects "another year of strong growth."

  • "We expect to deliver another year of strong growth and operational progress and enter 2023 with significant momentum across our business."

  • Guidance: For the second consecutive quarter, Insulet increased annual revenue guidance. Last quarter, it increased its projections from 12%-16% growth to 14%-17%. The company now expects a Y/Y improvement of 18%-19%.

  • Price Action: PODD shares traded 12.79% higher at $288.00 during premarket on the last check Friday.

See more from Benzinga

廣告

Don't miss real-time alerts on your stocks - join Benzinga Pro for free! Try the tool that will help you invest smarter, faster, and better.

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.